Brief: Multiply Labs Raises $75 Mln Series B Led By AstraZeneca, Teradyne
06/10/2026 19:31
BRIEF-Multiply Labs Raises $75 Mln Series B Led By AstraZeneca, Teradyne Oct 6 (Reuters) - Multiply Labs:
MULTIPLY LABS RAISES $75 MILLION SERIES B TO CLOSE THE GAP BETWEEN DRUG DISCOVERY AND DRUG MANUFACTURING
MULTIPLY LABS: ROUND LED BY ASTRAZENECA, LINGOTTO, TERADYNE, STRANGE VENTURES
Source text: ID:nBw6R97XRa
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsAstraZeneca says FDA approves drug for rare kidney disease in adults
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Early US flu season, current strain may signal risk for younger people; doctors urge shots
AstraZeneca partners with Oracle for AI-driven clinical trials
Factbox: Pharma sector doubles down on AI to slash costs, timelines